SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001178913-20-001753
Filing Date
2020-06-08
Accepted
2020-06-08 06:06:26
Documents
1
Period of Report
2020-05-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 5671
  Complete submission text file 0001178913-20-001753.txt   7797
Mailing Address HAREL HOUSE, 3 ABBA HILLEL ST. RAMAT GAN L3 52118
Business Address HAREL HOUSE, 3 ABBA HILLEL ST. RAMAT GAN L3 52118 972-3-7547090
Harel Insurance Investments & Financial Services Ltd. (Reporting) CIK: 0001429390 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-39279 | Film No.: 20948031

Mailing Address ABBA HILLEL 3 RAMAT GAN L3 5211802
Business Address ABBA HILLEL 3 RAMAT GAN L3 5211802 97237547090
Harel Insurance Co LTD (Reporting) CIK: 0001666482 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-39279 | Film No.: 20948030

Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)